%0 Journal Article
%T Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral Regimens
%A Amanda M. Farr
%A Ella T. Nkhoma
%A Lisa Rosenblatt
%A Stephen S. Johnston
%J Archive of "Open Forum Infectious Diseases".
%D 2016
%R 10.1093/ofid/ofw061
%K antiretroviral agents
%K efavirenz
%K human immunodeficiency virus
%K major adverse cardiovascular events
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866551/